Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts. - No Study Results Posted

Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts. (ETNA)

This study is currently recruiting participants.

Study NCT00058812 Information provided by Baylor College of Medicine

First Received: April 11, 2003 Last Updated: July 30, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	May 2013 (Final data collection date for primary outcome measure)